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Abstract
Infection prevention and control measures for COVID-19 may include immediate admission to an isolation facility for the
infected. However, the mental health impact of this isolation worldwide is not fully documented. This study aims to contribute to global data on the psychological impact of COVID-19 and to be the first study to assess psychological distress
among hospitalised patients with COVID-19 in the UAE. Using a cross-sectional study design on 132 hospitalised patients,
we found that 90% of participants scored within the normal levels for psychological distress. The length of stay was associated with higher levels of psychological distress and those aged 41–60 years had lower levels of psychological distress
compared to the 31–40 years group. Our results contributed to global data on the psychological impact of COVID-19 and
may help to identify those at risk for psychological distress due to COVID-19 hospitalisation for targeted prevention and
future pandemic preparedness plans.
Keywords COVID-19 · Mental health · Depression · Anxiety · Psychological distress · UAE
Abbreviations
COVID-19	Coronavirus disease of 2019
UAE	United Arab Emirates
SARS	Severe acute respiratory syndrome
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CI	Confidence interval
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1 Introduction
The Coronavirus disease of 2019 (COVID-19) outbreak
started in December 2019 in Wuhan, China, and swept
through the globe rapidly, achieving WHO Pandemic status by mid-March 2020 [1]. COVID-19-related restrictions
(infection prevention measures) have been applied worldwide and are regarded as an important measure to tackle
the COVID-19 spread. By April 2020, more than a third
of the global population was under COVID-19 movement
restrictions or lockdowns [2]. COVID-19 restrictions, such
as medical isolation, travel restrictions, and outdoor activity limitations have. In many cases, led to elevated levels of
stress and anxiety among those impacted [3].
The link between viral infection and psychological effects
among the survivors has been established [4]. Neuropsychiatric links have been established between Severe Acute
Respiratory Syndrome (SARS) in the early phase of the
illness and depression, anxiety, panic disorder, suicidality,
as well as delirium, and psychosis [5]. Data on the mental
health impact on the community at large is emerging from
many countries, and the prevalence of anxiety and depression has been reported to be more than doubled compared
to pre-COVID-19 periods as reported in Mexico, the United
Kingdom, and the United States [6]. A survey by the Indian
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Psychiatric Society reported a 20% increase in mental illness
in India since the pandemic [7]. Therefore, researchers have
urged that countries learn from the pandemic and recognize
the importance of public mental health and integrate it into
public health preparedness and disaster planning [8].
The United Arab Emirates (UAE) has been successful in
limiting the spread of COVID-19 through several preventive measures, including immediate admission to an isolation
facility for those infected with Coronavirus [9]. Isolation
among hospitalised patients with COVID-19 is needed due
to their high level of transmissibility [10]. Being isolated in
the hospital may produce psychological instability among
those with COVID-19 infection, due to a lack of interactions
with families and friends [11], as well as due to the COVID
pandemic situation [12]. A previous study showed that during the isolation period at the hospital, 57.2 and 52.2% of
hospitalised patients with COVID-19 infection had anxiety and depressive symptoms, respectively [10]. A crosssectional study in an Iranian community also revealed that
compared to the community samples, hospitalised patients
with COVID-19 infection had significantly higher anxiety,
depression, and stress levels as measured using The Depression, Anxiety and Stress Scale—21 Items (DASS-21) [13].
Studies from various countries on the mental health
impact of COVID-19 are being published, painting a global
picture. In the Middle East region, studies on the psychological impact of the COVID-19 pandemic among the general
population have been published [14, 15], however, the study
on the psychological impact of hospitalised patients with
COVID-19 infection in this region is very limited. Therefore, this study aims to contribute to global data on the psychological impact of COVID-19 and to be the first study to
assess the levels of depression, anxiety, and stress among
hospitalised patients with COVID-19 infection in the UAE.

2 Methods
2.1 Study Design, Study Population,
and Participants
We conducted a cross-sectional study via a researcheradministered questionnaire through a telephone call to all
consenting and medically stable COVID-19 patients hospitalised in isolation units in three health care facilities in
Abu Dhabi City, UAE. In this study, we used a purposive
or subjective sampling methods, a type of non-probability
convenience sampling technique in which the sample is
selected due to their characteristics and the objective of the
study [16]. We studied 132 patients who were diagnosed
with COVID-19 positive by reverse transcription polymerase
chain reaction (RT-PCR) laboratory test and were admitted
to COVID-19 isolation units in three participating health
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care facilities in Abu Dhabi city, UAE. We included all
patients aged 18 years or above, clinically stable patients or
vitals within normal limits, can communicate without difficulty, cognitively able to comprehend and respond to the
questionnaire. Our study excluded those less than 18 years
of age, clinically unstable patients (on ventilators or hemodynamic instability etc.), and cognitively impaired patients.

2.2 Data Collection
Recruitment of participants was carried out by approaching
leads of treatment teams in charge of the patients admitted to
COVID-19 isolation wards at the enlisted health care facilities from July 2020 to December 2020. Consenting teams
disseminated a copy of the consent form to the patients
under their care. The consent form was available in English/
Urdu/Hindi and Arabic. Patients who consent to participate
received a telephone call during their hospital stay from the
research team, who administered the questionnaire to the
patients and recorded the responses on an electronic portal
managed by the research team. Patient medical records were
not accessed, nor the patient’s identifiers were recorded for
the purpose of this study. A coordinator and co-researchers
were available to answer questions concerning the survey by
email or phone. The study was approved by the Department
of Health, Abu Dhabi Research Ethics Committee.

2.3 Questionnaire and Psychological Distress Scales
The survey instrument comprised of questions on demographic characteristics of post-traumatic stress, measured
by the Impact of Event Scale-Revised (IES-R), a 22-item
self-assessment questionnaire assessing the severity of distress because of a traumatic event [17]. Depression, anxiety, and stress levels measured by DASS-2 [18], a 21-item
self-assessment questionnaire. These two instruments have
been used worldwide to measure the impact of COVID-19
pandemic on mental health [19]. For each element in DASS21 scale, the participant indicated how much he/she was
disturbed or distressed in the last week by each of the difficulties listed using a Likert scale ranging from 0 "Not at
all" to 4 "Extremely”. A total score was calculated by adding
the scores of all elements (range 0–88). The total depression,
anxiety, and stress scores using IES-R scale were reported
in continuous form, while the score of each element using
DASS-21 scale was categorized into five categories; normal, mild, moderate, severe, and extremely severe. Due to
significant correlations between IES-R and DASS-21 scales
in capturing psychological distress, we assessed the levels
of psychological distress measured by the IES-R scale as an
outcome in our regression analysis. Furthermore, to ensure
its reliability, we evaluated the Cronbach’s alpha score of
the IES-R in this study.
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3 Statistical Analysis
The sociodemographic distribution was calculated in terms
of contingency tables of the n (%). The Mann–Whitney U
test or Kruskal–Wallis test was performed to examine variation in post-traumatic stress disorder levels according to
sociodemographic category. Spearman's correlation with
95% confidence interval (95% CI) was performed to analyse
the association between the level of psychological distress
measured by IES-R scale and the levels of depression, anxiety, and stress measured by DASS-21 scale.
Univariate and multivariate ordinal logistic (proportional
odds) regression models were fitted with the level of psychological distress as an outcome. The predictors were age
group, gender, nationality, marital status, presence of medical condition or comorbidity, and length of hospital stay.
Odds ratios (OR) and 95% confidence interval (95% CI)
were reported with the corresponding Wald’s z and p values.
Statistical analyses were performed in R version 4.0.5 [20].
All applied statistical tests were two-sided; p value < 0.05
were considered statistically significant. No adjustment for
multiple comparisons was made.

4 Results
Table 1 shows DASS-21, frequency (percentage) of the level
of stress, depression, and anxiety of the COVID-19 patients
included in this statistical analysis. 93.2, 80.3, and 95.5% of
the patients were in a normal range of depression, anxiety,
and stress, respectively. Table 1 illustrates the cut-off values
used to diagnose the level of expression, anxiety, and stress.
Figure 1 shows the distribution of the total IES-R score
in gender, age, presence of medical condition, nationality,
and marital status category. A statistically significant gender
Table 1  DASS-21 frequency
(percentage) of the level
of stress, depression,
and anxiety among study
participants, and their DASS-21
cut off scores

difference was found in stress disorder levels (Wilcoxon p
value = 0.017), with females scoring higher. Furthermore,
statistically significant age differences were observed in
stress disorder levels (Kruskal Wallis p value = 0.011)
with those in the 41–50 age group having the lowest levels.
Moreover, statistically significant differences in stress disorder levels were observed between the nationality group
(p = 0.04, Kruskal–Wallis test). No statistically significant
difference was observed in medical condition and marital
status groups, Kruskal–Willis p value of 0.855 and 0.241,
respectively.
Figure 2 presents scatterplots of the distribution of IES-R
score, Anxiety, Depression, and Stress score, respectively.
Spearman rank correlation with corresponding 95% confidence interval was estimated and was all statistically significant p value < 0.001.
Table 2 presents the result of the fitted univariate
and multivariate logistic (Proportional Odds) ordinal regression model. Univariately, male is less likely
to develop depression than female with Odds ratio
(OR) = 0.46, and 95% Confidence Interval (CI) = 0.25,
0.87, p value = 0.016). However, no statistically significant difference was observed between females and males
OR = 0.818 (95% CI 0.389–1.720, p value = 0.596) in
the multivariate analysis after adjusting for age, presence of medical condition, marital status, nationality and
the length of hospital stay. Statistically significant differences were observed between age group (41–50) and
(51–60) as compared to the reference group (31–40 years)
in univariate and multivariate analysis; OR = 0.233 (95%
CI 0.099–0.545, p value = 0.001) and 0.352 (95% CI
0.148–0.835, p value = 0.018) in univariate analysis, and
OR = 0.194 (95% CI 0.077–0.493, p value = 0.001) and
0.248 (95% CI 0.089–0.688, p value = 0.007) in multivariate analysis, respectively (Table 2). The length of hospital stay was statistically significant in both univariate and

DASS-21 frequency (percentage) of the level of
Stress, Depression, and anxiety
Normal
Mild
Moderate
Severe
Extremely severe
DASS-21 cut off scores
Normal
Mild
Moderate
Severe
Extremely severe

Depression

Anxiety

Stress

123 (93.2)
5 (3.8)
4 (3)
0 (0)
0 (0)

106 (80.3)
12 (9.1)
10 (7.6)
4 (3)
0 (0)

126 (95.5)
5 (3.8)
1 (0.8)
0 (0)
0 (0)

0–9
10–13
14–20
21–27
28 +

0–7
8–9
10–14
15–19
20 +

1–4
15–18
19–25
26–33
34 +
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Fig. 1  Distribution of the total IES-R score in the gender, age, nationality, and marital status groups. Wilcoxon p-value for gender and Kruskal–
Wallis p-value for age, nationality, and marital status.*Other: Divorced/Widow

multivariate analysis, that is, the risk of stress increases as
length of hospital stay increases with an OR = 1.053 (95%
CI 1.016–1.091, p value = 0.004) for each day of stay in
univariate analysis and OR = 1.059 (95% CI 1.010–1.10, p
value = 0.018) for each day of stay in multivariate analysis.
No statistically significant differences were observed for
those with a medical condition, however, after adjusting
for confounding factors, those with a medical condition
had higher levels of psychological distress compared to
those without a medical condition; OR = 1.77 (95% CI
0.985–3.489, p value = 0.101). Those with Arab nationality were also shown to have higher levels of psychological distress compared to those with Filipino nationality as
a reference group, although not statistically significant;
OR = 1.72 (95% CI 0.657–4.491, p value = 0.270).

13

5 Discussion
To our knowledge, this is the first study to investigate the
mental health impact of COVID-19 among COVID-19 inpatients in the UAE. The study results indicated that in the
population of hospitalised patients with COVID-19 infection, the proportions of depression, anxiety, and stress levels
were low (below screening cut-off) in the majority (90%) of
the patients as measured using the DASS-21 scale. Additionally, the IES-R scores were also below the screening
cut-off points, which indicates normal levels of psychological distress. Our findings were similar to the findings
from other Middle Eastern countries reporting psychological impact scores of the COVID-19 pandemic among their
general population as measured using the IES-R scale [14,

Journal of Epidemiology and Global Health

Fig. 2  Distribution of IES-R score, Anxiety, Depression, and Stress score, respectively. Spearman rank correlation with corresponding 95% confidence interval. All estimated Spearman correlations were statistically significant, p value < 0.001

15]. Our findings, however, diverge from another UAE study
that assessed the impact of COVID-19 on depression and
anxiety among healthcare professionals in UAE. The study
in question reported 51.5 and 38.3% of study participants
experiencing clinically significant levels of anxiety and
depressive symptoms, respectively [21]. Unlike the general
population in our study, the frontline healthcare professional
is known to experience significant work-related stress and
anxiety due to work overload as well as fear of COVID-19
infection [22]. A previous study among a similar population
to our study has found a high prevalence of psychological
distress, namely anxiety and depressive symptoms, among
Bangladeshi COVID-19 hospitalised patients [10]. Previous studies have also suggested that incompetent healthcare

systems and treatment negligence in the healthcare facilities as possible mechanisms to explain the high prevalence
of psychological distress among hospitalised COVID-19
patients [23, 24]. Therefore, we believe the normal levels of
psychological distress among our participants in our current
study can also be attributed to the health care system in Abu
Dhabi and an overall COVID-19 control and management
in the UAE.
In this study, we found that the IES-R used in our study
was reliable as the Cronbach’s alpha score of the IES-R
(Bootstrap 95% confidence interval based on 1000 samples) was 0.93 (95% CI 0.908–0.949). The IES-R scale has
been validated and has been frequently used for assessing the psychological impact of COVID-19 infections
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Table 2  Univariate and multivariate ordinal logistic (proportional odds) regression analysis of factors associated with psychological distress
level or an increased score of IES-R score
N (%)

Univariate

Multivariate
a

OR (95% CI)
Female
Male
Medical condition
No
Yes
Age
31–40
18–30
41–50
51–60
61+
Married
Divorced/Widow
Single
Nationality
Filipino
Arab
Indian
Others
UAE
Length of hospital stay
median (IQR)

b

Z (p value)

OR (95% CI)a

Z (p value)b

82 (62.1%)
50 (37.9%)

Reference
0.462 (0.247, 0.865)

– 2.412 (0.016)

Reference
0.816 (0.386, 1.705)

– 0.551 (0.582)

64 (48.5%)
68 (51.5%)

Reference
1.058 (0.584, 1.916)

0.186 (0.853)

Reference
1.767 (0.985, 3.489)

1.639 (0.101)

18 (13.6%)
40 (30.3%)
32 (24.2%)
26 (19.7%)
16 (12.1%)
8 (6.1%)
100 (75.8%)
24 (18.2%)

Ref
0.708 (0.267, 1.877)
0.233 (0.099, 0.545)
0.352 (0.148, 0.835)
0.312 (0.110, 0.886)
Reference
0.823 (0.203, 3.340)
1.880 (0.876, 4.034)

30 (22.7%)
31 (23.5%)
9 (6.8%)
39 (29.5%)
21 (15.9%)
13.5 (4–27.5)

Reference
0.637 (0.286, 1.422)
0.270 (0.116, 0.627)
0.662 (0.184, 2.385)
0.379 (0.146, 0.979)
1.053 (1.016, 1.091)

– 0.272 (0.786)
1.620 (0.105)

Ref
1.006 (0.324, 3.122)
0.194 (0.077, 0.493)
0.248 (0.089, 0.688)
0.322 (0.081, 1.280)
Reference
0.544 (0.115, 2.581)
0.580 (0.221, 1.526)

– 0.766 (0.444)
– 1.103 (0.270)

– 1.100 (0.271)
– 3.041 (0.002)
– 0.631 (0.528)
– 2.004 (0.045)
2.860 (0.004)

Reference
1.718 (0.657, 4.491)
0.470 (0.173, 1.280)
0.807 (0.210, 3.102)
0.587 (0.172, 2.002)
1.059 (1.010, 1.110)

1.103 (0.270)
– 1.477 (0.140)
– 0.312 (0.755)
– 0.850 (0.395)
2.370 (0.018)

– 0.694 (0.488)
– 3.359 (0.001)
– 2.370 (0.018)
– 2.188 (0.029)

0.010 (0.992)
– 3.448 (0.001)
– 2.678 (0.007)
– 1.609 (0.108)

Frequency (percentage) for categorical data and median (IQR interquartile range) for the length of stay
a

b

Estimated odds ratios (OR) with 95% CI
Wald’s z value, and corresponding p values

internationally, for example, in Jordan [15], China [25],
Iran [26], and Italy [27]. Our regression analysis revealed
that the length of hospital stay was significantly associated
with higher levels of psychological distress (depression,
anxiety, and stress) as measured using IES-R score, independent of age, gender, medical condition, marital status,
and nationality. This finding is in agreement with an integrative review which confirmed that hospitalisation experience negatively affected patients’ psychological wellbeing and increased feelings of depression and anxiety
among adult patients regardless of the reason for admission [28]. An Iranian study on 152 patients with COVID19 infection also revealed that 26% COVID-19 inpatients
reported moderate to high levels of anxiety and depression
[26]. Environmental factors (such as sunlight exposure in
patients' rooms), social factors (such as financial difficulties), and health-related factors (such as illness severity
and disease symptoms) have been shown to contribute to
a poor hospitalisation experience [29, 30]. Therefore, we
believe the aforementioned mechanisms may also explain
our findings with possibly an additional factors from
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COVID-19-related treatments (such as COVID-19 medication and physical discomfort) [10].
Our study also found that patients aged 41–60 years
were significantly associated with lower levels of psychological distress, compared to patients aged 31–40 years. A
Chinese study suggested the amount of time spent focusing on COVID-19-related information as the mechanism in
explaining more prevalent cases of anxiety and depressive
symptoms among those aged 35 years or below, compared
to their older counterparts [31]. In addition, another previous study also found that individuals aged 35 years or below
were more likely to have anxiety and depressive symptoms
during the COVID-19 pandemic [32]. The exact mechanism
on the effect of age on the psychological distress among
hospitalised patients with COVID-19 is not fully understood.
We did not find any significant associations between other
predictors, namely marital status, nationality, or presence
of medical condition and psychological distress among
hospitalised patients with COVID-19. However, those
with medical condition or those with Arab nationality had
strong magnitude of associations of psychological distress
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compared to their respective reference. We have a different
finding with an Iranian study that found being divorced was
associated with higher psychological load (depression and
anxiety) among COVID-19 inpatients [26]. On a different
note, the association between presence of medical condition or comorbidity and psychological impact among hospitalised patients has been established. We have a different
finding from a previous study in hospitalised patients with
COVID-19 found that presence of comorbidity was significantly associated with anxiety and depressive symptoms,
independent of COVID-19 severity [10]. Different population characteristics and the limitation of telephone survey to
confirm or classify the medical condition in our study may
contribute to these differences. Finally, our findings on the
association between nationality and psychological impact
among COVID-19 inpatients showed that the effect of race
on psychological distress due to COVID-19 pandemic especially in the Middle East may be worth further investigation.

6 Strengths and Limitations
This is the first study on the psychological impact of
COVID-19 among hospitalised COVID-19 patients in the
UAE. We were able to control for important confounding
factors such as age, gender, presence of medical condition,
and length of stay. Our study used two psychological distress
scales (IES-R and DASS-21 scales) to assess the levels of
anxiety, depression, and stress in our study population. The
high intercorrelation between the two scales indicates a high
reliability of our data. However, we did not assess the validity of these two scales in this study, thus, studies assessing
its validity in this population are warranted.
Despite the aforementioned strengths, our study has several limitations. First, we employed a purposive or subjective sampling design and only included a small number of
participants, therefore, not only we had low power to detect
differences, but also reduced the study’s external validity
or generalizability. However, we recruited the study participants from COVID-19 isolation units in three healthcare
facilities in Abu Dhabi, to increase the representativeness of
our study samples. We also did not have medical records to
compare with their pre-existing psychiatric conditions, and
we do not have any control inpatients groups for comparison
purposes. Next, we had no follow-up after discharge from
hospitals, therefore, the long-term consequences of COVID19 infection on mental health among our participants are still
unknown. The period during which the data was collected
between 14 July 2020 and 19 December 2020, may have a
bearing on the findings as the changing face of the pandemic
at that time period of survey may have affected the responses
of participants. The telephone interview methodology may
also pose certain challenges as this method only can serve

to collect the baseline information on variables of interest,
thus, could not include severe COVID-19 inpatients. Lastly,
as in other observational studies, this present study is also
prone to residual and unmeasured confounding (such as
socioeconomic status and medication), which could influence the psychological impact in our population.

7 Conclusions
Our results on the psychological impact of COVID-19
among hospitalised patients may help to identify those at
risk for psychological distress due to COVID-19 hospitalisation. Early identification and targeted treatment of those at
risk for psychological distress due to COVID-19 hospitalisation for targeted prevention and future pandemic preparedness plans. Future studies on the long-term consequences of
COVID-19 infection on mental health among ever-hospitalised patients infected with COVID-19 are warranted.
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